Lucid Diagnostics Inc. (LUCD) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 38 transactions totaling $8.2M, demonstrating a bullish sentiment with $8.0M in net insider flow. The most recent transaction on Feb 20, 2026 involved a transaction of 123,000 shares valued at $0.
No significant insider buying has been recorded for LUCD in the recent period.
No significant insider selling has been recorded for LUCD in the recent period.
Based on recent SEC filings, insider sentiment for LUCD is bullish with an Insider Alignment Score of 99/100 and a net flow of $8.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Lucid Diagnostics Inc. (LUCD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading LUCD stock, having executed 38 transactions in the past 90 days. The most active insider is Inc. Pavmed (Executive), who has made 13 transactions totaling $25.6M.
Get notified when executives and directors at LUCD file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | L. Cox James | Executive | Award | 123,000 | $N/A | $0 | |
| Feb 20, 2026 | Lapidus Stanley | Executive | Award | 123,000 | $N/A | $0 | |
| Feb 20, 2026 | R. Palumbo John | Executive | Award | 123,000 | $N/A | $0 | |
| Feb 20, 2026 | J. Sokolov Jacque | Executive | Award | 123,000 | $N/A | $0 | |
| Feb 20, 2026 | M. Sparks Ronald | Executive | Award | 123,000 | $N/A | $0 | |
| Aug 20, 2025 | Matheis Dennis | Executive | Purchase | 100,000 | $1.02 | $102.0K | |
| May 7, 2024 | Aklog Lishan | Executive | Award | 400,000 | $N/A | $0 | |
| May 7, 2024 | M. Mcgrath Dennis | Executive | Award | 400,000 | $N/A | $0 | |
| May 7, 2024 | O'neil Shaun | Executive | Award | 400,000 | $N/A | $0 | |
| May 7, 2024 | Adam Gordon Michael | Executive | Award | 400,000 | $N/A | $0 | |
| Feb 15, 2024 | Pavmed Inc. | Executive | Other | 3,331,747 | $N/A | $0 | |
| Jan 26, 2024 | Pavmed Inc. | Executive | Other | 3,331,771 | $1.40 | $4.7M | Large |
| Sep 26, 2023 | Lapidus Stanley | Executive | Sale | 9,747 | $1.45 | $14.1K | 10b5-1 |
| Sep 26, 2023 | Lapidus Stanley | Executive | Sale | 10,000 | $1.43 | $14.3K | 10b5-1 |
| Sep 26, 2023 | Lapidus Stanley | Executive | Sale | 10,000 | $1.47 | $14.7K | 10b5-1 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Other(J) | 12 | $17.6M | 68.2% |
Purchase(P) | 2 | $8.1M | 31.4% |
Sale(S) | 12 | $112.5K | 0.4% |
Award(A) | 12 | $0 | 0.0% |
Insiders at Lucid Diagnostics Inc. are accumulating shares at an accelerated pace. With 11 insiders making 38 transactions totaling $8.1M in purchases versus $112.5K in sales, the net buying activity of $8.0M signals strong executive confidence. Inc. Pavmed (Executive) leads the buying activity with $25.6M in transactions across all time.